Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taro Shuin

Showing results (71-80 of 180) with videos related to

Pageof 18
Sort By:
Cancer Research|July 1, 2010
Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cellsYosuke Harada, Mitsugu Kanehira, Yoshiko Fujisawa, et al.
Pathology International|March 3, 2004
Low-grade tubular-mucinous renal neoplasm with neuroendocrine differentiation: a histological, immunohistochemical and ultrastructural studyNaoto Kuroda, Shoichiro Nakamura, Eriko Miyazaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinomaKeiji Inoue, Takashi Karashima, Satoshi Fukata, et al.
Plos One|September 3, 2015
The Utility of a Flexible Fluorescence-Cystoscope with a Twin Mode Monitor for the 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis of Bladder CancerHideo Fukuhara, Mitsuhiro Kureishi, Takeo Khoda, et al.
International Journal of Molecular Sciences|February 25, 2023
Role of SOCS and VHL Proteins in Neuronal Differentiation and DevelopmentHiroshi Kanno, Shutaro Matsumoto, Tetsuya Yoshizumi, et al.
Molecular and Clinical Oncology|April 29, 2016
Feasibility and early outcome of high-dose-rate Ir-192 brachytherapy as monotherapy in two fractions within 1 day for high-/very high-risk prostate cancerShingo Ashida, Ichiro Yamasaki, Kenji Tamura, et al.
Nephron. Experimental Nephrology|October 30, 2008
Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidneyMitsuko Iguchi, Yoshihiko Kakinuma, Atsushi Kurabayashi, et al.
Oncology Reports|January 17, 2009
Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cellsSachiko Dobashi, Toyomasa Katagiri, Eiji Hirota, et al.
BMC Urology|July 21, 2014
IgG4-related tubulointerstitial nephritis accompanied with cystic formationHideo Fukuhara, Yoshinori Taniguchi, Manabu Matsumoto, et al.
BMC Urology|September 28, 2021
Evaluation of a rapid one-step PSA test for primary prostate cancer screeningShingo Ashida, Ichiro Yamasaki, Chiaki Kawada, et al.
Pageof 18

Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Cancer Research|July 1, 2010
Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cellsYosuke Harada, Mitsugu Kanehira, Yoshiko Fujisawa, et al.
Pathology International|March 3, 2004
Low-grade tubular-mucinous renal neoplasm with neuroendocrine differentiation: a histological, immunohistochemical and ultrastructural studyNaoto Kuroda, Shoichiro Nakamura, Eriko Miyazaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinomaKeiji Inoue, Takashi Karashima, Satoshi Fukata, et al.
Plos One|September 3, 2015
The Utility of a Flexible Fluorescence-Cystoscope with a Twin Mode Monitor for the 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis of Bladder CancerHideo Fukuhara, Mitsuhiro Kureishi, Takeo Khoda, et al.
International Journal of Molecular Sciences|February 25, 2023
Role of SOCS and VHL Proteins in Neuronal Differentiation and DevelopmentHiroshi Kanno, Shutaro Matsumoto, Tetsuya Yoshizumi, et al.
Molecular and Clinical Oncology|April 29, 2016
Feasibility and early outcome of high-dose-rate Ir-192 brachytherapy as monotherapy in two fractions within 1 day for high-/very high-risk prostate cancerShingo Ashida, Ichiro Yamasaki, Kenji Tamura, et al.
Nephron. Experimental Nephrology|October 30, 2008
Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidneyMitsuko Iguchi, Yoshihiko Kakinuma, Atsushi Kurabayashi, et al.
Oncology Reports|January 17, 2009
Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cellsSachiko Dobashi, Toyomasa Katagiri, Eiji Hirota, et al.
BMC Urology|July 21, 2014
IgG4-related tubulointerstitial nephritis accompanied with cystic formationHideo Fukuhara, Yoshinori Taniguchi, Manabu Matsumoto, et al.
BMC Urology|September 28, 2021
Evaluation of a rapid one-step PSA test for primary prostate cancer screeningShingo Ashida, Ichiro Yamasaki, Chiaki Kawada, et al.
Pageof 18